"The FDA often looks to its panels of outside experts for advice about experimental therapies before making approval decisions and usually follows their recommendations."
Funny, how past panels have recommended Genasense for approval then the FDA turns around and denies the NDA.
I hope the FDA feels the pressure this time around. Alot of eyes will be following their forthcoming descisions.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.